Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

NCT01188603 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexual Dysfunctions, Psychological

Interventions

DRUG: flibanserin 100 mg dose every evening

Sponsor

Sprout Pharmaceuticals, Inc